Anti-VEGF treatment (follow up) 24h after treatment I Before treatment I 7 days after treatment I 30 days after treatment I Before treatment II 24h after treatment II 10 days after treatment II 30 days after treatment II 24h after treatment III
Myopic CNV Marco Pellegrini , MD, Sacco Hospital, Rome, Italy FA ICGA Angio OCT
Non-flow Area Manage Non perfusion More Closely AngioOCT Scan Showing Non-Perfusion Automatic Border Detection of Area of Non-Perfusion Non Flow Area (mm2): 1.845
Quantitative change in NDR Dimitrova G, Chihara E, Takahashi H, Amano H, Okazaki K. Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy. IOVS. 2017;58:190–196.
Flow Area Density (Progression) OCTA Capillary Perfusion Density Maps and Values provide an easy way to grade progressive vascular change Prof. Toco Chui, Prof. Richard Rosen, Mount Sinai Hospital, New York, USA Normal Mild NPDR Moderate NPDR Severe NPDR PDR
Reduced RPC Blood Flow in Glaucoma Dr. Min Wang, EENT hospital of Fudan University, Shanghai, China
Pubmed - Optical Coherence Tomography Angiography
OCTA
To be or not to be? Suqin Yu, MD., Shanghai General Hospital, China
FAZ Tool (DR Follow-Up) Images Courtesy: Créteil University Hospital, France (Prof. E. Souied & Dr A. Miere) 2015: FAZ= 0.560 mm 2 2017: FAZ= 0.640 mm 2 FAZ 2015 2017 Area 0.56 0.64 Perim 3.388 3.709 AI 1.28 1.31
Proliferative Diabetic Retinopathy Marco Pellegrini , MD, Sacco Hospital, Rome, Italy Angio OCT FA
Proliferative Diabetic Retinopathy Enface (RTVue XR) OCTA (RTVue XR) FAG Dr. Zhao Yue, Dr. Yao Jin, Nanjing Medical University Affiliated Eye Hospital, China
Angio OCT Structural Enface NAION Dr. Min Wang, EENT hospital of Fudan University, Shanghai, China
Flow area CNV treatment (follow up)
1000+ users global Books & Atlases 702 OCTA papers (2018/11)
Macular flow / structural change in Glaucoma normal moderate advanced